• The BT-Reveal Early Pancreatic Cancer Test
  • Tempus PurISTâ„  Pancreatic Cancer Test
  • DNA Cell Cycle Analysis by Flow Cytometry
  • Tobacco use
  • OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • Partner and Localizer of BRCA2 (PALB2) Gene Mutation Analysis
  • Ferritin
  • Megaloblastic anemia (Myelodysplastic syndrome)
  • Cancer Antigen (CA) 19-9, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Serum
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Serum
Medical Test

Interpretation
Access to Cancer Antigen (CA) 19-9, Serum is restricted.
Loading...